Stocks and Investing Stocks and Investing
Wed, March 16, 2022
Tue, March 15, 2022
Mon, March 14, 2022
Fri, March 11, 2022

Jason Butler Maintained (VRDN) at Buy with Decreased Target to $31 on, Mar 11th, 2022


Published on 2024-10-27 20:03:54 - WOPRAI, Jason Butler
  Print publication without navigation


Jason Butler of JMP Securities, Maintained "Viridian Therapeutics, Inc." (VRDN) at Buy with Decreased Target from $36 to $31 on, Mar 11th, 2022.

Jason has made no other calls on VRDN in the last 4 months.



There is 1 other peer that has a rating on VRDN. Out of the 1 peers that are also analyzing VRDN, 0 agree with Jason's Rating of Hold.



This is the rating of the analyst that currently disagrees with Jason


  • Thomas Smith of "SVB Leerink" Initiated at Buy and Held Target at $32 on, Thursday, November 18th, 2021